Koers Rock Creek Pharmaceuticals Inc Nasdaq
Aandelen
US7720812046
Farmaceutische producten
Omzet 2014 | - | Omzet 2015 | - | Marktkapitalisatie | 8,21 mln. 7,57 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -38 mln. -35,07 mln. | Nettowinst (verlies) 2015 | -6 mln. -5,54 mln. | EV/omzet 2014 | - |
Nettoliquiditeiten 2014 | 45K 41,53K | Nettoschuld 2015 | 19,86 mln. 18,32 mln. | EV/omzet 2015 | - |
K/w-verhouding 2014 |
-0,87
x | K/w-verhouding 2015 |
-1,04
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+36,90% | 723 mld. | |
+32,22% | 598 mld. | |
-1,96% | 364 mld. | |
+20,32% | 331 mld. | |
+3,67% | 288 mld. | |
+16,60% | 244 mld. | |
+9,77% | 210 mld. | |
-5,15% | 208 mld. | |
+8,66% | 169 mld. |